CDSCO Panel opins Abbott Healthcare to Conduct Phase III CT of Clarithromycin ER Tablets 1000mg Dr. Divya Colin14 May 2024 6:00 PM ISTNew Delhi: Citing that there is no specific unmet medical need, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
J&J Gets CDSCO Panel Nod to study anti-cancer drug Talquetamab Dr. Divya Colin22 Dec 2023 6:00 PM ISTNew Delhi: The drug major Johnson and Johnson has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
AstraZeneca gets CDSCO panel Nod To study antihypertensive drug Baxdrostat Dr. Divya Colin9 Dec 2023 9:34 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Torrent Pharma gets CDSCO Panel nod to study Brexpiprazole tablet to treat schizophrenia Dr. Divya Colin26 Nov 2023 5:00 PM ISTNew Delhi: Citing that the clinical trial sites should be geographically distributed in the country, the Subject Expert Committee (SEC) functional...
Lupin Gets CDSCO Panel Nod To Manufacture, Market FDC of Glycopyrronium, Vilanterol Inhalation Powder Dr. Divya Colin5 Sept 2023 6:00 PM ISTNew Delhi: The drug major Lupin has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel denies Nacto Pharma's request To Waive Phase III CT of Anticancer Erdafitinib tablet Dr. Divya Colin13 Aug 2023 6:00 PM ISTNew Delhi: Rejecting the waiver of Phase III clinical trial proposal for Erdafitinib Tablets 3mg, 4mg, and 5mg, the Subject Expert Committee (SEC)...
Monitor endometrioma size of clinical trial participants: CDSCO panel tells Abbott India on Dydrogesterone Dr. Divya Colin12 Jun 2023 6:00 PM ISTNew Delhi: Suggesting monitoring the size of the endometrioma of participating subjects during the clinical trial, the Subject Expert Committee (SEC)...
Conduct Phase III CT: CDSCO Panel Tells Sun Pharma on Liraglutide solution for injection PFP Dr. Divya Colin21 May 2023 6:00 PM ISTNew Delhi: Responding to the proposal presented by drug major Sun Pharma, for manufacturing and marketing the antidiabetic drug Liraglutide 6 mg/ml...
Revise CT protocol: CDSCO Panel tells Intas on antipsychotic Drug Endoxifen Dr. Divya Colin27 March 2023 6:00 PM ISTNew Delhi: Noting that the study drug Endoxifen is already approved in India since 10-12-2019 for proposed indication, the Subject Expert Committtee...
MSN Lab gets CDSCO Panel nod for phase III CT of Elagolix Tablets Dr. Divya Colin19 Feb 2023 6:00 PM ISTNew Delhi: The drug major MSN Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Pure & Cure Healthcare Gets CDSCO Panel nod To study Latanoprost,Netarsudil Mesylate Ophthalmic Solution Dr. Divya Colin16 Oct 2022 1:29 PM ISTNew Delhi: Pure and Cure Healthcare has got a go-ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
Novartis Gets CDSCO Panel Nod To Study Ianalumab Dr. Divya Colin4 Sept 2022 11:17 AM ISTNew Delhi: In a significant development, drug major Novartis has got a green signal from the Subject Expert Committee (SEC) functional under the...
